Biotechnology · Cambridge, United Kingdom · Founded 2003 · Privately Held (backing)
Operator of a clinical-stage cancer therapy biotechnology company intended to focus on novel drug development for specific cancers. CellCentric is based in Cambridge, United Kingdom and was founded in 2003. It is valued at about $382 million as of Oct 2026, set by institutional fund marks. It has raised $281 million across 2 recorded rounds; the latest was an $116 million Series C in Apr 2025.
PMV mark · valuation
$382.5M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$280.5M
Last round
Later Stage VC (Series C)
Apr 2025
Team — not yet on record
No current team members for CellCentric are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of CellCentric with a free account
·The complete investor list: 20 names
·Watch CellCentric: the Monday email on marks, rounds and moves
